Boston Scientific Corporation
BSXCompany Overview
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.
Country
US
Market Cap
$84.98B
Last Fiscal Year
2023
Final Shariah Status
Passed
Compliance Analysis Overview
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
0.00%
passed
Liabilities Compliance
11.17%
passed
Final Shariah Status
Passed
This stock meets all Shariah compliance criteria according to AAOIFI standards.
Stock Information
| Name | Boston Scientific Corporation |
| Ticker | BSX |
| Main Business | Medical devices |
| Type | Securities |
| Industry | Medical Devices |
| Country | US |
| Market Cap | $84.98 B |
Shariah Analysis Breakdown
Business compliance Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| MedSurg | $5,057.0 | $0.0 | - |
| Cardiovascular | $8,161.0 | $0.0 | - |
| Total | $13,218.0 | $0.0 | 0.00% (passed) |
Liabilities Compliance Breakdown
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $531,000,000.0 | 0.62% |
| long term debt and capital lease obligation | $8,960,000,000.0 | 10.54% |
| Total Interest-Bearing Debt | $9,491,000,000.0 | 11.17% |
| Market Capitalization | $84,980,700,000.0 | 100.00% |
| Compliance Status | Threshold: 33% | passed |